Date Log
Assessment on role of clinical pharmacist in adverse drug reaction reporting: a questionnaire based study
Corresponding Author(s) : Shailaja K
International Journal of Allied Medical Sciences and Clinical Research,
Vol. 5 No. 1 (2017): 2017 Volume 5- Issue -1
Abstract
Objectives
To create awareness about the existing ADR reporting system in the hospital, importance of ADR reporting and to identify the barriers of under reporting among the healthcare professionals.
Methods
It was a prospective, interventional study carried out in tertiary care hospital, Kanchipuram District for a period of six months from September 2011 to February 2012. A well designed closed ended questionnaire was used to assess the awareness of ADR reporting and the barriers of under reporting.
Results
A total of 154 questionnaires were circulated among the healthcare professionals, of whom only 125 questionnaires were filled by the healthcare professionals, the remaining 29 healthcare professionals were not willing to fill the questionnaire due to lack of time. Majority of the respondents were (59) 47% doctors, (20) 16% pharmacist and (46) 36.7% nurses and the barriers were mainly found to be lack of confidence, lack of time and fear of negative report.
Conclusion
The present study concluded that the educational intervention made by the clinical pharmacist regarding ADR reporting was very useful.
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
-
Monica Zolezzi and Nirasha Parsotam, Adverse drug reaction reporting in New Zealand: implications for
pharmacists, Therapeutic Clinical Risk Management. 1, 2005, 181–188.
[2]. Rawlins M, Thompson W. Mechanisms of adverse drug reactions. In: Davies D, Ed. Textbook of adverse
drug reactions. New York: Oxford University Press 1991, 18-45.
[3]. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, and Car J, Majeed A: Trends in ho spital
admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998 –
2005. BMC Clinical Pharmacology 2007, 7.
[4]. Pouyanne P, Haramburu F, Imbs JL, Bégaud B: Admissions to hospital caused by adverse drug reactions:
cross sectional incidence study. French Pharmacovigilance Centres. British Medical Journal 2000, 320:
1036.
[5]. Vikas Dhikav, Sindhu Singh, KS Anand, Adverse drug reaction reporting in India: Journal, Indian Academy
of Clinical Medicine January-March, 5(1), 2004, 27-33.
[6]. Mandavi, Sanjay D’Cruz, Atul Sachdev & Pramil Tiwari, Adverse drug reactions & their risk factors
among Indian ambulatory elderly patients: Indian Journal Med Res, 2012, 404-410.
[7]. Santosh KC, Pramote Tragulpiankit, Sarun Gorsanan, and I Ralph Edwards, Attitudes among healthcare
professionals to the reporting of adverse drug reactions in Nepal, BMC Pharmacology and Toxicology
2013, 14:16.
[8]. Lopez-Gonzalez E, Herdeiro MT, Figueiras A: Determinants of under - reporting of adverse drug reactions:
a systematic review. Drug Safety 2009, 32:19–31.
[9]. TFDA, Guidelines for monitoring and reporting adverse drug reactions, 2006.
References
pharmacists, Therapeutic Clinical Risk Management. 1, 2005, 181–188.
[2]. Rawlins M, Thompson W. Mechanisms of adverse drug reactions. In: Davies D, Ed. Textbook of adverse
drug reactions. New York: Oxford University Press 1991, 18-45.
[3]. Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, and Car J, Majeed A: Trends in ho spital
admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998 –
2005. BMC Clinical Pharmacology 2007, 7.
[4]. Pouyanne P, Haramburu F, Imbs JL, Bégaud B: Admissions to hospital caused by adverse drug reactions:
cross sectional incidence study. French Pharmacovigilance Centres. British Medical Journal 2000, 320:
1036.
[5]. Vikas Dhikav, Sindhu Singh, KS Anand, Adverse drug reaction reporting in India: Journal, Indian Academy
of Clinical Medicine January-March, 5(1), 2004, 27-33.
[6]. Mandavi, Sanjay D’Cruz, Atul Sachdev & Pramil Tiwari, Adverse drug reactions & their risk factors
among Indian ambulatory elderly patients: Indian Journal Med Res, 2012, 404-410.
[7]. Santosh KC, Pramote Tragulpiankit, Sarun Gorsanan, and I Ralph Edwards, Attitudes among healthcare
professionals to the reporting of adverse drug reactions in Nepal, BMC Pharmacology and Toxicology
2013, 14:16.
[8]. Lopez-Gonzalez E, Herdeiro MT, Figueiras A: Determinants of under - reporting of adverse drug reactions:
a systematic review. Drug Safety 2009, 32:19–31.
[9]. TFDA, Guidelines for monitoring and reporting adverse drug reactions, 2006.
